<DOC>
	<DOCNO>NCT00686504</DOCNO>
	<brief_summary>The study carry order determine relationship AZD2066 exposure mGluR5 receptor occupancy brain demonstrate AZD2066 displace [ 11C ] AZ12713580 mGluR5 binding-sites Central Nervous System</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) Study With 11CAZ12713580 Determine Central mGluR5 Receptor Occupancy AZD2066</brief_title>
	<detailed_description />
	<criteria>Provision inform consent BMI ( Body Mass Index ) ≥19 ≤28 kg/m2 weight ≥50 ≤100 kg Normal MRI ( Magnetic Resonance Imaging ) scan visit 2 History previous ongoing psychiatric disease condition include psychosis , affective disorder , anxiety disorder , borderline state personality disorder accord criterion Diagnostic Statistical Manual Mental Disorders History psychotic disorder among first degree relative ( parent , sibling ) History use antipsychotic , antidepressant anxiolytic ( anxiety treatment ) drug , prescribe nonprescribed use . History antidepressant anxiolytic nonpsychiatric condition pain postoperative insomnia allow</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Pain</keyword>
	<keyword>PET</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>mGlu5 receptor</keyword>
	<keyword>Dose find</keyword>
	<keyword>Analgesia/Pain</keyword>
</DOC>